Quantitative structure-retention relationships in the examination of the topography of the binding site of antihistamine drugs on α1-acid glycoprotein

Journal of Chromatography A

Volumn 722, Issue 1-2, 1996, Pages 25-32

  Kaliszan, Roman ^a   Nasal, Antoni ^a   Turowski, Maciej ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAZOLINE; ANTIHISTAMINIC AGENT; CHLOROPYRAMINE; CHLORPHENIRAMINE; CINNARIZINE; DIMETINDENE; DIPHENHYDRAMINE; ISOTHIPENDYL; KETOTIFEN FUMARATE; MEPYRAMINE MALEATE; OROSOMUCOID; PHENIRAMINE; PIZOTIFEN; PROMETHAZINE; ROXATIDINE; TRIPELENNAMINE; TRIPROLIDINE; TYMAZOLINE;

BINDING SITE; CONFERENCE PAPER; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

BINDING SITES; CHEMISTRY, PHYSICAL; HISTAMINE H1 ANTAGONISTS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; OROSOMUCOID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030062868     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9673(95)00523-4     Document Type: Article

References (24)

1. R. Kaliszan, Quantitative Structure-Chromatographic Retention Relationships, Wiley, New York, 1987.
2. R. Kaliszan, Adv. Chromatogr., 33 (1993) 147.
3. C. Hansch and A. Leo, Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley, New York, 1979.
4. C. Pidgeon, C. Marcus and F. Alvarez, in T.D. Baldwin and I.W. Kelly (Editors), Applications of Enzyme Biotechnology, Plenum Press, New York, 1992, p. 201.
5. R. Kaliszan, A. Kaliszan and I.W. Wainer, J. Pharm. Biomed. Anal., 11 (1993) 505.
6. S. Ong, H. Liu, X. Qiu, G. Bhat and C. Pidgeon, Anal. Chem., 67 (1995) 755.
7. R. Kaliszan, A. Nasal and A. Buciński, Eur. J. Med. Chem., 29 (1994) 163.
8. J.M.H. Kremer, J. Wilting and L.H.M. Janssen, Pharmacol. Rev., 40 (1988) 1.
9. W.E. Müller, in I.W. Wainer and D.E. Drayer (Editors), Drug Stereochemistry: Analytical Methods and Pharmacology, Marcel Dekker, New York, 1988, p. 227.
10. S. Allenmark, B. Bomgren and H. Borén, J. Chromatogr., 237 (1982) 473.
11. J. Hermansson, J. Chromatogr., 298 (1984) 67.
12. E. Domenici, C. Bertucci, P. Salvadori, S. Motellier and I.W. Wainer, Chirality, 2 (1990) 263.
13. R.C. Jewell, K.L.R. Brouwer and P.J. McMamara, J. Chromatogr., 487 (1989) 257.
14. T.A.G. Noctor, C.D. Pham, R. Kaliszan and I.W. Wainer, Mol. Pharmacol., 42 (1992) 506.
15. T.A.G. Noctor, M.J. Diaz-Perez and I.W. Wainer, J. Pharm. Sci., 82 (1993) 675.
16. A. Nasal, A. Radwańska, K. Ośmialowski, A. Buciński, R. Kaliszan, G.E. Barker, P. Sun and R.A. Hartwick, Biomed. Chromatogr., 8 (1994) 125.
17. Y.H. Chu, L.Z. Avila, H.A. Biebuyck and G.M. Whitesides, J. Org. Chem., 58 (1993) 648.
18. R. Kaliszan, J. Chromatogr. A, 656 (1993) 417.
19. R. Kaliszan, T.A.G. Noctor and I.W. Wainer, Mol. Pharmacol., 42 (1992) 512.
20. L.Z. Benet and R.L. Williams, in A. Goodman Gilman, T.W. Rall, A.S. Nies and P. Taylor (Editors), The Pharmacological Basis of Therapeutics, Pergamon Press, New York, 1991, p. 1650.
21. W.H. Pirkle and C.J. Welch, J. Liq. Chromatogr., 14 (1991) 2027.
22. J.M.H. Kremer, J. Wiltig and L.H.M. Janssen, Pharmacol. Rev., 40 (1988) 1.
23. F. Brunner and W.E. Müller, J. Pharm. Pharmacol., 39 (1987) 986.
24. L. Šoltés, B. Sébille and P. Szalay, J. Pharm. Biomed. Anal., 12 (1994) 1295.